Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 54(1): 198-202, 2023 Jan.
Artigo em Zh | MEDLINE | ID: mdl-36647667

RESUMO

Objective: To prepare cell membrane nanovesicles (NVs) derived from breast cancer cells, to explore their basic characteristics, tumor cell endocytosis, and in vivo distribution in a tumor-bearing mouse model, and to investigate their tumor targeting properties. Methods: 4T1 breast cancer cells were cultured in vitro. The cell membrane of 4T1 cells was isolated through ultracentrifugation and NVs were formulated with a liposome extruder. The size distribution of NVs was determined by way of dynamic light scattering, and the morphology properties of the NVs were examined with transmission electron microscope. The stability of NVs was analyzed by measuring the diameter changes of NVs submerged in phosphate-buffered saline (PBS). The biocompatibility of NVs was investigated by measuring the viability of dendritic cells treated with NVs at different concentrations (5, 10, 20, 50, and 100 mg·L -1) by CCK-8 assay. Fluorescence microscopy was used to analyze the cellular uptake of NVs by breast cancer cells. A mice model of breast cancer model was established with mice bearing subcutaneous xenograft of 4T1 cells. The mice were treated with Cy5.5-labeled NVs injected via the tail vein and the in vivo distribution of NVs was analyzed with an imaging system for small live animals. Results: The results showed that NVs derived from 4T1 breast cancer cells were successfully prepared. The NVs had a mean diameter of 123.2 nm and exhibited a hollow spherical structure under transmission electron microscope. No obvious change in the size of the NVs was observed after 7 days of incubation in PBS solution. CCK-8 assay results showed that the viability of dendritic cells treated with NVs at different concentrations was always higher than 90%. Fluorescence microscopic imaging showed that NVs could be efficiently internalized into breast cancer cells. in vivo biodistribution analysis revealed that breast cancer cell-derived NVs showed higher distribution in tumor tissue than the NVs prepared with normal cells did. Conclusion: We successfully prepared cell membrane NVs derived from 4T1 breast cancer cells. These NVs had efficient cellular uptake by breast cancer cells and sound tumor targeting properties.


Assuntos
Neoplasias da Mama , Humanos , Camundongos , Animais , Feminino , Distribuição Tecidual , Membrana Celular/metabolismo , Linhagem Celular Tumoral , Lipossomos , Neoplasias da Mama/metabolismo
2.
Acta Pharmacol Sin ; 40(12): 1568-1577, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31197245

RESUMO

c-Maf is a critical oncogenic transcription factor that contributes to myelomagenesis. Our previous studies demonstrated that the deubiquitinase USP5 stabilizes c-Maf and promotes myeloma cell proliferation and survival; therefore, the USP5/c-Maf axis could be a potential target for myeloma therapy. As a concept of principle, the present study established a USP5/c-Maf-based luciferase system that was used to screen an FDA-approved drug library. It was found that mebendazole, a typical anthelmintic drug, preferentially induced apoptosis in c-Maf-expressing myeloma cells. Moreover, oral administration of mebendazole delayed the growth of human myeloma xenografts in nude mice but did not show overt toxicity. Further studies showed that the selective antimyeloma activity of mebendazole was associated with the inhibition of the USP5/c-Maf axis. Mebendazole downregulated USP5 expression and disrupted the interaction between USP5 and c-Maf, thus leading to increased levels of c-Maf ubiquitination and subsequent c-Maf degradation. Mebendazole inhibited c-Maf transcriptional activity, as confirmed by both luciferase assays and expression measurements of c-Maf downstream genes. In summary, this study identified mebendazole as a USP5/c-Maf inhibitor that could be developed as a novel antimyeloma agent.


Assuntos
Antineoplásicos/uso terapêutico , Mebendazol/uso terapêutico , Mieloma Múltiplo/tratamento farmacológico , Proteínas Proto-Oncogênicas c-maf/metabolismo , Proteases Específicas de Ubiquitina/metabolismo , Animais , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Cianoacrilatos/uso terapêutico , Reposicionamento de Medicamentos , Sinergismo Farmacológico , Feminino , Células HEK293 , Humanos , Camundongos Endogâmicos BALB C , Camundongos Nus , Mieloma Múltiplo/metabolismo , Estudo de Prova de Conceito , Ligação Proteica/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-maf/química , Piridinas/uso terapêutico , Proteases Específicas de Ubiquitina/química , Ubiquitinação/efeitos dos fármacos , Ensaios Antitumorais Modelo de Xenoenxerto
3.
J Biomed Mater Res B Appl Biomater ; 107(6): 2132-2139, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-30636102

RESUMO

Linear fluorinated polyamides with reversible cationic charges are feasibly prepared to be used as highly efficient gene vectors in HEK293 cell line. Due to the uniform polymer structure, the relationship between the physicochemical properties and transfection efficiency could be unambiguously investigated. The different efficiency in the application of gene delivery between the parent polyethylenimine (PEI) and the polyamides is directly associated with the differences in chemical and physical properties between secondary amines and fluorinated amides. We found that fluorination not only increases the cellular uptake of polymer/DNA polyplexes, but it also decreases cytotoxicity in terms of inducing lower concentrations of proinflammatory cytokine TNF-α. © 2019 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 2132-2139, 2019.


Assuntos
DNA , Halogenação , Hidrocarbonetos Fluorados , Polietilenoimina , Transfecção , DNA/química , DNA/farmacologia , Células HEK293 , Humanos , Hidrocarbonetos Fluorados/síntese química , Hidrocarbonetos Fluorados/química , Hidrocarbonetos Fluorados/farmacologia , Polietilenoimina/síntese química , Polietilenoimina/química , Polietilenoimina/farmacologia
4.
Int J Pharm ; 570: 118648, 2019 Oct 30.
Artigo em Inglês | MEDLINE | ID: mdl-31465833

RESUMO

Skin is the first protection of human body. It is always challenged by a range of external factors, resulting in the wounds of skin. Hydrogel, as a dressing with multiple advantages, causes increasing interests or the applications in wound treatment. However, the function and importance of micro-environment of wound region are frequently neglected. In this study, we successfully developed a chemokine loaded biomimetic hydrogel as a functional reservoir to stimulate the rapid in situ recruitment of BMSCs for fast wound repair and regeneration. The biomimetic hydrogel was fabricated by using the Polyvinyl alcohol (PVA) combined with chitosan (CS) as the hybrid materials. The fabricated hydrogel possesses many features such as the porous structure, high swelling rate and moisture retention property. More importantly, the incorporated chemokine could be released with a sustained manner from the hydrogel and recruited the bone marrow mesenchymal stem cells (BMSCs) significantly both in vitro & in vivo. Moreover, the hydrogel was demonstrated to be highly biocompatible to the skin tissue without any side effect or irritation observed. Topical delivery of chemokine by the biomimetic PVA/CS hybrid material based hydrogel is demonstrated as a promising carrier to accelerate wound repair and regeneration without inducing scar formation and any other negative complications. The PVA/CS/SDF-1 hydrogel was shown a novel therapeutic system for wound therapy.


Assuntos
Materiais Biomiméticos/administração & dosagem , Materiais Biomiméticos/química , Quimiocinas/metabolismo , Regeneração/efeitos dos fármacos , Cicatrização/efeitos dos fármacos , Animais , Bandagens , Biomimética/métodos , Medula Óssea/efeitos dos fármacos , Medula Óssea/metabolismo , Quitosana/química , Sistemas de Liberação de Medicamentos/métodos , Humanos , Hidrogéis/química , Células-Tronco Mesenquimais/efeitos dos fármacos , Células-Tronco Mesenquimais/metabolismo , Álcool de Polivinil/química , Ratos , Ratos Sprague-Dawley , Pele/efeitos dos fármacos , Pele/metabolismo
5.
PLoS One ; 11(3): e0152206, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27015268

RESUMO

Tooth morphogenesis is initiated by reciprocal interactions between the ectoderm and neural crest-derived mesenchyme, and the Wnt signaling pathway is involved in this process. We found that Plakophilin (PKP)1, which is associated with diseases such as ectodermal dysplasia/skin fragility syndrome, was highly expressed in teeth and skin, and was upregulated during tooth development. We hypothesized that PKP1 regulates Wnt signaling via its armadillo repeat domain in a manner similar to ß-catenin. To determine its role in tooth development, we performed Pkp1 knockdown experiments using ex vivo organ cultures and cell cultures. Loss of Pkp1 reduced the size of tooth germs and inhibited dental epithelial cell proliferation, which was stimulated by Wnt3a. Furthermore, transfected PKP1-emerald green fluorescent protein was translocated from the plasma membrane to the nucleus upon stimulation with Wnt3a and LiCl, which required the PKP1 N terminus (amino acids 161 to 270). Localization of PKP1, which is known as an adhesion-related desmosome component, shifted to the plasma membrane during ameloblast differentiation. In addition, Pkp1 knockdown disrupted the localization of Zona occludens 1 in tight junctions and inhibited ameloblast differentiation; the two proteins were shown to directly interact by immunoprecipitation. These results implicate the participation of PKP1 in early tooth morphogenesis as an effector of canonical Wnt signaling that controls ameloblast differentiation via regulation of the cell adhesion complex.


Assuntos
Diferenciação Celular/genética , Odontogênese/genética , Placofilinas/genética , Dente/metabolismo , Ameloblastos/metabolismo , Adesão Celular/genética , Proliferação de Células , Desmossomos/metabolismo , Humanos , Dente Molar/crescimento & desenvolvimento , Dente Molar/metabolismo , Técnicas de Cultura de Órgãos , Placofilinas/metabolismo , Dente/crescimento & desenvolvimento , Via de Sinalização Wnt/genética , Proteína Wnt3A/genética , Proteína Wnt3A/metabolismo , beta Catenina/genética , beta Catenina/metabolismo
6.
J Zhejiang Univ Sci B ; 14(11): 1025-32, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24190448

RESUMO

OBJECTIVE: To observe the periodontal healing of autogenously transplanted teeth loaded orthodontically after autotransplantation in Beagle dogs. METHODS: Forty-eight teeth were autogenously transplanted, 24 of which were loaded postoperatively with orthodontic force at different time points and for different durations. Periodontal healing was evaluated by probing pocket depth (PPD), the expression of relevant proteins, and histomorphometric analyses. RESULTS: The dental pockets of loaded and non-loaded teeth were both much deeper after the first postoperative week than before transplantation (P<0.05). Later, the PPD, which was measured after postoperative weeks 1, 3, 5, 9 and 13, gradually became shallow. The expressions of alkaline phosphatase (ALP) and basic fibroblast growth factor (bFGF) were higher in loaded teeth than in non-loaded teeth (P<0.05), and in groups subjected to two weeks duration of loading than in other groups at the same load time point (P<0.05). For the same load duration, the expressions of ALP and bFGF in teeth loaded after postoperative week 4 were higher than those of other treatments (P<0.05). According to histomorphometric analyses, an orthodontic force on transplanted teeth applied after postoperative weeks 4 or 8 for two weeks duration should be favorable for periodontal healing. CONCLUSIONS: It is advisable to apply an appropriate magnitude of force on autotransplanted teeth, such as orthodontic force, at appropriate time points and for a suitable duration, to achieve the optimal clinical prognosis following autogenous tooth transplantation. These results may serve as a basis for subsequent studies in humans so as to make clinical improvements.


Assuntos
Periodonto/patologia , Dente/transplante , Fosfatase Alcalina/genética , Animais , Cães , Fator 2 de Crescimento de Fibroblastos/genética , Masculino , Periodonto/metabolismo , RNA Mensageiro/análise , Transplante Autólogo
7.
J Virol Methods ; 179(2): 390-5, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22172971

RESUMO

The porcine boca-like virus (Pbo-likeV) was recently discovered in Swedish pigs with post-weaning multisystemic wasting syndrome (PMWS). In this study, a loop-mediated isothermal amplification (LAMP) assay was developed for rapid, specific and sensitive detection of Pbo-likeV. A set of four primers specific for six regions of Pbo-likeV VP1/2 genes was designed with the online software. The reaction temperature and time were optimized to 65 °C and 60 min, respectively. LAMP products were detected by agarose gel electrophoresis or by visual inspection of a color change due to addition of fluorescent dye. The developed method was highly specific for detection of Pbo-likeV, and no cross-reaction was observed with other swine viruses, such as porcine reproductive and respiratory syndrome virus (PRRSV), porcine circovirus type 2 (PCV2), porcine parvovirus (PPV) and classic swine fever virus (CSFV) found commonly in China. The lower detection limit of the LAMP assay was approximately 10 copies per reaction, and it was 100 times more sensitive than that of conventional PCR. Furthermore, the efficiency of LAMP for detection Pbo-likeV in clinical samples was comparable to PCR and sequencing. These results showed that the LAMP assay is a simple, rapid, sensitive and specific technique for detection of Pbo-likeV, and the procedure of LAMP does not rely on any special equipment. It has capacity for the detection of Pbo-likeV both in the laboratory and on farms.


Assuntos
Bocavirus/isolamento & purificação , Técnicas de Diagnóstico Molecular/métodos , Técnicas de Amplificação de Ácido Nucleico/métodos , Infecções por Parvoviridae/veterinária , Doenças dos Suínos/diagnóstico , Medicina Veterinária/métodos , Virologia/métodos , Animais , China , Primers do DNA/genética , DNA Viral/química , DNA Viral/genética , Dados de Sequência Molecular , Infecções por Parvoviridae/virologia , Sensibilidade e Especificidade , Análise de Sequência de DNA , Suínos , Doenças dos Suínos/virologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA